Variant report

Variant	nsv508215
Chromosome Location	chr1:57319460-57351150
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr1:57322753-57323057	HepG2	liver:	n/a	n/a
2	ARID3A	chr1:57319785-57320899	HepG2	liver:	n/a	n/a
3	CEBPB	chr1:57343061-57343196	K562	blood:	n/a	n/a
4	CEBPB	chr1:57345334-57345515	HepG2	liver:	n/a	n/a
5	CEBPB	chr1:57319925-57320524	HepG2	liver:	n/a	chr1:57320038-57320055 chr1:57320039-57320050
6	CEBPB	chr1:57322725-57323064	HepG2	liver:	n/a	chr1:57322886-57322897
7	CTCF	chr1:57334300-57334450	AoAF	blood vessel:	n/a	n/a
8	CTCF	chr1:57343020-57343170	GM12865	blood:	n/a	n/a
9	CTCF	chr1:57340505-57340524	GM13976	blood:	n/a	n/a
10	CTCF	chr1:57340155-57340197	GM20000	blood:	n/a	n/a
11	CUX1	chr1:57344029-57344032	K562	blood:	n/a	n/a
12	CUX1	chr1:57322672-57322707	GM12878	blood:	n/a	n/a
13	E2F4	chr1:57335173-57335373	MCF10A-Er-Src	breast:	n/a	n/a
14	EP300	chr1:57332172-57332846	SK-N-SH	brain:	n/a	chr1:57332222-57332230
15	EP300	chr1:57319998-57320908	HepG2	liver:	n/a	n/a
16	EP300	chr1:57319821-57320891	HepG2	liver:	n/a	n/a
17	EP300	chr1:57320116-57320737	HepG2	liver:	n/a	n/a
18	FOSL2	chr1:57332171-57332918	SK-N-SH	brain:	n/a	n/a
19	FOXA1	chr1:57320007-57320885	HepG2	liver:	n/a	n/a
20	FOXA1	chr1:57320014-57320882	HepG2	liver:	n/a	n/a
21	FOXA1	chr1:57319970-57320945	HepG2	liver:	n/a	n/a
22	FOXA1	chr1:57320058-57320761	HepG2	liver:	n/a	n/a
23	FOXA2	chr1:57319818-57320818	HepG2	liver:	n/a	n/a
24	FOXA2	chr1:57319896-57320908	HepG2	liver:	n/a	n/a
25	GATA2	chr1:57347431-57347771	SH-SY5Y	brain:	n/a	n/a
26	GATA3	chr1:57332210-57333039	SK-N-SH	brain:	n/a	n/a
27	GATA3	chr1:57330003-57330586	SK-N-SH	brain:	n/a	n/a
28	GATA3	chr1:57332194-57332980	SK-N-SH	brain:	n/a	n/a
29	GATA3	chr1:57347568-57347652	SH-SY5Y	brain:	n/a	n/a
30	HDAC2	chr1:57320023-57320840	HepG2	liver:	n/a	chr1:57320283-57320297
31	HDAC2	chr1:57320120-57320876	HepG2	liver:	n/a	chr1:57320283-57320297
32	HEY1	chr1:57320302-57320901	HepG2	liver:	n/a	n/a
33	HEY1	chr1:57320921-57321315	HepG2	liver:	n/a	n/a
34	HEY1	chr1:57320092-57321245	HepG2	liver:	n/a	n/a
35	HNF4A	chr1:57320081-57320459	HepG2	liver:	n/a	chr1:57320323-57320337 chr1:57320321-57320339 chr1:57320322-57320337 chr1:57320322-57320337
36	HNF4A	chr1:57320124-57320750	HepG2	liver:	n/a	chr1:57320323-57320337 chr1:57320321-57320339 chr1:57320322-57320337 chr1:57320322-57320337
37	HNF4G	chr1:57320062-57320565	HepG2	liver:	n/a	chr1:57320323-57320337 chr1:57320321-57320336 chr1:57320321-57320339 chr1:57320337-57320352 chr1:57320322-57320337
38	HNF4G	chr1:57319994-57320583	HepG2	liver:	n/a	chr1:57320323-57320337 chr1:57320321-57320336 chr1:57319996-57320011 chr1:57319996-57320011 chr1:57320321-57320339 chr1:57320337-57320352 chr1:57320322-57320337 chr1:57319996-57320011
39	IRF1	chr1:57350359-57350362	K562	blood:	n/a	n/a
40	JUN	chr1:57331450-57331502	HepG2	liver:	n/a	n/a
41	JUN	chr1:57345404-57345467	HepG2	liver:	n/a	chr1:57345414-57345427
42	JUND	chr1:57332266-57332947	SK-N-SH	brain:	n/a	n/a
43	JUND	chr1:57332224-57332835	SK-N-SH	brain:	n/a	n/a
44	MAFF	chr1:57338329-57338572	K562	blood:	n/a	n/a
45	MAFK	chr1:57332409-57332602	HepG2	liver:	n/a	n/a
46	MAFK	chr1:57320178-57320555	HepG2	liver:	n/a	chr1:57320328-57320343
47	MAFK	chr1:57332350-57332550	HepG2	liver:	n/a	n/a
48	MAFK	chr1:57332216-57332761	IMR90	lung:	n/a	n/a
49	MAX	chr1:57332172-57332667	SK-N-SH	brain:	n/a	n/a
50	MAX	chr1:57327682-57327688	HepG2	liver:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr1:57320685-57320735	HRE	kidney:	n/a
2	chr1:57320685-57320735	AG04449	skin:	fetal
3	chr1:57320685-57320735	HCT-116	colon:	n/a
4	chr1:57320685-57320735	GM19239	blood:	n/a
5	chr1:57320685-57320735	NHDF-neo	bronchial:	n/a
6	chr1:57320685-57320735	HCF	heart:	n/a
7	chr1:57320685-57320735	U87	brain:	n/a
8	chr1:57320685-57320735	CMK	blood:	n/a
9	chr1:57320685-57320735	HAEpiC	amniotic membrane:	n/a
10	chr1:57320685-57320735	HPAEpiC	pulmonary alveolar:	n/a
11	chr1:57320685-57320735	HMEC	breast:	n/a
12	chr1:57320685-57320735	PFSK-1	brain:	n/a
13	chr1:57320685-57320735	HEEpiC	esophagus:	n/a
14	chr1:57320685-57320735	ProgFib	skin:	n/a
15	chr1:57320685-57320735	T-47D	breast:	n/a
16	chr1:57320685-57320735	ovcar-3	ovarian:	n/a
17	chr1:57320685-57320735	Caco-2	colon:	n/a
18	chr1:57320685-57320735	HUVEC	blood vessel:	n/a
19	chr1:57320685-57320735	GM12891	blood:	n/a
20	chr1:57320685-57320735	AG10803	skin:	n/a
21	chr1:57320685-57320735	NT2-D1	testis:	n/a
22	chr1:57320685-57320735	Hela-S3	cervix:	n/a
23	chr1:57320685-57320735	AoSMC	blood vessel:	n/a
24	chr1:57320685-57320735	HCPEpiC	choroid plexus:	n/a
25	chr1:57320685-57320735	AG09319	gingival:	n/a
26	chr1:57320685-57320735	SK-N-SH	brain:	n/a
27	chr1:57320685-57320735	Jurkat	blood:	n/a
28	chr1:57320685-57320735	SAEC	small airway:	n/a
29	chr1:57320685-57320735	AG09309	skin:	n/a
30	chr1:57320685-57320735	HRPEpiC	eye:	n/a
31	chr1:57320685-57320735	A549	lung:	n/a
32	chr1:57320685-57320735	HCM	heart:	n/a
33	chr1:57320685-57320735	HRCEpiC	kidney:	n/a
34	chr1:57320685-57320735	HIPEpiC	eye:	n/a
35	chr1:57320685-57320735	NB4	blood:	n/a
36	chr1:57320685-57320735	HL-60	blood:	n/a
37	chr1:57320685-57320735	HNPCEpiC	eye:	n/a
38	chr1:57320685-57320735	NH-A	brain:	n/a
39	chr1:57320685-57320735	BE2_C	brain:	n/a
40	chr1:57320685-57320735	PrEC	prostate:	n/a
41	chr1:57320685-57320735	MCF10A-Er-Src	breast:	n/a
42	chr1:57320685-57320735	GM12892	blood:	n/a
43	chr1:57320685-57320735	PANC-1	pancreas:	n/a
44	chr1:57320685-57320735	Hepatocyte	liver:	n/a
45	chr1:57320685-57320735	IMR90	lung:	fetal
46	chr1:57320685-57320735	MCF-7	breast:	n/a
47	chr1:57320685-57320735	ECC-1	luminal epithelium:	n/a
48	chr1:57320685-57320735	RPTEC	kidney:	n/a
49	chr1:57320685-57320735	H1-hESC	embryonic stem cell:	embryo
50	chr1:57320685-57320735	AG04450	lung:	fetal

No.	Distal block	Cell Line	Cell type
1	chr1:57343676..57345366-chr1:57354019..57355791,2	K562	blood:
2	chr1:57327047..57329042-chr1:57332021..57334016,2	K562	blood:
3	chr1:57335538..57338188-chr1:57354917..57357199,2	K562	blood:
4	chr1:57343866..57346444-chr1:57354291..57357261,2	K562	blood:
5	chr1:57327047..57329042-chr1:57332021..57334016,2	K562	blood:

Variant related genes	Relation type
C8A	TF binding region
C8A	CpG island

Extended variants
information (count: 1249 )
Associated
traits (count: 93 )

Variant overlapped rSNPs/rCNVs (count:1249 , 50 per page) page: 1 2 3 4 5 6 7 ... 25

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs671137	chr1:57319480-57319481	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs191113959	chr1:57319512-57319513	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs557780317	chr1:57319552-57319553	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs183323494	chr1:57319561-57319562	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs537003908	chr1:57319574-57319575	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs78606308	chr1:57319601-57319602	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs1329449	chr1:57319629-57319630	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
8	rs542824161	chr1:57319678-57319679	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs552878234	chr1:57319680-57319681	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs573121801	chr1:57319715-57319716	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs682584	chr1:57319716-57319717	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs537312425	chr1:57319737-57319738	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs533167576	chr1:57319764-57319765	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs543381169	chr1:57319777-57319778	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs563455042	chr1:57319817-57319818	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs150321140	chr1:57319824-57319825	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs549580718	chr1:57319830-57319831	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs566137500	chr1:57319832-57319833	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs528820118	chr1:57319910-57319911	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs187275517	chr1:57319912-57319913	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs137984243	chr1:57319931-57319932	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs537065748	chr1:57319942-57319943	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs532411722	chr1:57319944-57319945	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs556961587	chr1:57319973-57319974	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs149393032	chr1:57319998-57319999	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs12074992	chr1:57320023-57320024	Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs374539545	chr1:57320050-57320051	Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs145812358	chr1:57320051-57320052	Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs190514128	chr1:57320075-57320076	Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs559327491	chr1:57320079-57320080	Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs545150320	chr1:57320116-57320117	Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs72913444	chr1:57320210-57320211	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs529642091	chr1:57320262-57320263	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs367624016	chr1:57320276-57320277	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs116591874	chr1:57320317-57320318	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs561970322	chr1:57320327-57320328	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs138462595	chr1:57320330-57320331	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs557540509	chr1:57320333-57320334	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs114037173	chr1:57320427-57320428	Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs183096969	chr1:57320442-57320443	Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs72670315	chr1:57320444-57320445	Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs114991676	chr1:57320487-57320488	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs187731564	chr1:57320535-57320536	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs143035893	chr1:57320557-57320558	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs552319150	chr1:57320558-57320559	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs192696675	chr1:57320600-57320601	Active TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs267598665	chr1:57320625-57320626	Active TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs113852423	chr1:57320653-57320654	Active TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs112742526	chr1:57320654-57320655	Active TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs184240619	chr1:57320660-57320661	Active TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:93)

Disease	PMID	Source
Papillary thyroid carcinoma	21436994	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Colorectal cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Coronary Disease	20032323	CNVD
Prostate cancer	21965145	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Stargardt''s disease	17277736	CNVD
Neuroblastoma	17897457	CNVD
Uveal melanoma	21693616	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-syndromic sensorineural hearing loss	22290220	CNVD
Liposarcoma	21253554	CNVD
Breast cancer	21264507	CNVD
Acute myeloid leukemia	16864856	CNVD
Astrocytoma	17387387	CNVD
Cancer	21499728	CNVD
Glioblastoma multiforme	17387387	CNVD
Oligodendroglial tumors	17285580	CNVD
Neuroblastoma	17535989	CNVD
Pheochromocytoma	17535989	CNVD
Prostate cancer	16705090	CNVD
Astrocytoma	17934521	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Neuroblastoma	17533364	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Autism	22495311	CNVD
Non-small cell lung cancer	21385341	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Chordoma	21602918	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Melanoma	18172304	CNVD
Multiple myeloma	16461302	CNVD
Melanoma	17363583	CNVD
Cancer	21129771	CNVD
Autosomal dominant nocturnal frontal lobe epilepsy	18472482	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-small cell lung cancer	20864512	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Thrombocytopenia-absent radius syndrome	21933853	CNVD
Psychiatric disorder	22848183	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Hepatocellular carcinoma	16750200	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	20409316	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	17393978	CNVD
Cervical cancer	21062161	CNVD
Cancer	21183584	CNVD
Breast cancer	21785460	CNVD
Breast cancer	21364760	CNVD
Rett syndrome	21593744	CNVD
Meckel-Gruber syndrome	21572526	CNVD
Breast cancer	16620391	CNVD
Multiple myeloma	16616336	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Prostate cancer	16573809	CNVD
Breast cancer	16608533	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21509527	CNVD
Myelofibrosis	22110671	CNVD
Developmental delay	19490664	CNVD
Glioblastoma multiforme	22286061	CNVD
Ovarian cancer	21720365	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:131 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:57315800-57320000	Enhancers	HepG2	liver
2	chr1:57316600-57323200	Enhancers	Fetal Intestine Small	intestine
3	chr1:57318200-57320000	Enhancers	Liver	Liver
4	chr1:57319000-57320400	Weak transcription	Duodenum Mucosa	Duodenum
5	chr1:57319200-57320200	Weak transcription	Fetal Intestine Large	intestine
6	chr1:57320000-57320200	Flanking Active TSS	Liver	Liver
7	chr1:57320000-57320400	Flanking Active TSS	HepG2	liver
8	chr1:57320200-57320600	Enhancers	Stomach Mucosa	stomach
9	chr1:57320200-57321200	Enhancers	Fetal Intestine Large	intestine
10	chr1:57320200-57324000	Active TSS	Liver	Liver
11	chr1:57320400-57320600	Active TSS	Duodenum Mucosa	Duodenum
12	chr1:57320400-57320600	Active TSS	HepG2	liver
13	chr1:57320600-57320800	Flanking Active TSS	Duodenum Mucosa	Duodenum
14	chr1:57320600-57320800	Flanking Active TSS	HepG2	liver
15	chr1:57320600-57321600	Weak transcription	Stomach Mucosa	stomach
16	chr1:57320800-57321400	Enhancers	Duodenum Mucosa	Duodenum
17	chr1:57320800-57321800	Active TSS	HepG2	liver
18	chr1:57321400-57322000	Weak transcription	Duodenum Mucosa	Duodenum
19	chr1:57321600-57321800	Enhancers	Stomach Mucosa	stomach
20	chr1:57321800-57322200	Flanking Active TSS	HepG2	liver
21	chr1:57322000-57322200	Enhancers	Duodenum Mucosa	Duodenum
22	chr1:57322200-57322800	Enhancers	HepG2	liver
23	chr1:57322800-57323200	Flanking Active TSS	HepG2	liver
24	chr1:57323200-57324400	Enhancers	HepG2	liver
25	chr1:57324000-57324600	Flanking Active TSS	Liver	Liver
26	chr1:57324400-57339000	Weak transcription	HepG2	liver
27	chr1:57324600-57325200	Enhancers	Liver	Liver
28	chr1:57325200-57325400	Flanking Active TSS	Liver	Liver
29	chr1:57325400-57325800	Enhancers	Liver	Liver
30	chr1:57325800-57327400	Genic enhancers	Liver	Liver
31	chr1:57327400-57327800	Enhancers	Liver	Liver
32	chr1:57327800-57330400	Weak transcription	Liver	Liver
33	chr1:57329000-57329800	Enhancers	Fetal Intestine Small	intestine
34	chr1:57329000-57330600	Enhancers	Fetal Intestine Large	intestine
35	chr1:57329600-57330000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
36	chr1:57329800-57330600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
37	chr1:57330000-57330600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
38	chr1:57330000-57330600	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
39	chr1:57330000-57330600	Enhancers	NHDF-Ad	bronchial
40	chr1:57330400-57330600	Enhancers	NHEK	skin
41	chr1:57330400-57331400	Strong transcription	Liver	Liver
42	chr1:57330600-57331600	Weak transcription	NHDF-Ad	bronchial
43	chr1:57330600-57331800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
44	chr1:57330600-57332200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
45	chr1:57330600-57333200	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
46	chr1:57331200-57332200	Weak transcription	NHEK	skin
47	chr1:57331400-57332400	Weak transcription	Liver	Liver
48	chr1:57331600-57332200	Enhancers	NHDF-Ad	bronchial
49	chr1:57331800-57332200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
50	chr1:57332000-57332200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links